Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry Eye

NCT00987727 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Syndromes
Keratoconjunctivitis Sicca

Interventions

DRUG: carboxymethylcellulose 0.5% , glycerin 0.9% (OPTIVE® MD)
DRUG: sodium hyaluronate 0.18% (VISMED® Multi)

Sponsor

Allergan